Table 3.

Adverse events after MRgFUS thalamotomy (N = 48).

Subgroups	Frame-related AEs	Sonication-related AEs	Thalamotomy-related AEs				Others
			Sensory-related	Strength-related	Balance-related	Dysarthria and dysphagia
0 day	0 (0)	27 (56.3)	2 (4.2)	0 (0)	0 (0)	0 (0)	3 (6.3)
1 day	0 (0)	2 (4.2)	4 (8.3)	2 (4.2)	40 (83.3)	1 (2.1)	3 (6.3)
1 week	1 (2.1)	1 (2.1)	3 (6.3)	3 (6.3)	20 (41.7)	1 (2.1)	10 (20.8)
1 month	0 (0)	0 (0)	5 (10.4)	3 (6.3)	5 (10.4)	2 (4.2)	7 (14.6)
3 months	0 (0)	0 (0)	4 (8.3)	2 (4.2)	3 (6.3)	2 (4.2)	8 (16.7)
6 months	0 (0)	0 (0)	3 (6.3)	2 (4.2)	2 (4.2)	0 (0)	5 (10.4)
1 year	0 (0)	0 (0)	3 (6.3)	2 (4.2)	0 (0)	0 (0)	3 (6.3)
2 years	0 (0)	0 (0)	4 (8.3)	0 (0)	0 (0)	0 (0)	0 (0)

AEs, Adverse Events; MRgFUS, Magnetic Resonance-guided Focused Ultrasound.

Data were presented as numbers (%).